Traditional Chinese medicine for recurrent pregnancy loss: A systematic review and network meta-analysis

Zilin LONG; Houyu ZHAO; Fengqi LIU; Meng ZHANG; Junchang LIU; Siyan ZHAN; Feng SUN

Return

Traditional Chinese medicine for recurrent pregnancy loss: A systematic review and network meta-analysis

Author: Zilin LONG ¹ ; Houyu ZHAO ² ; Fengqi LIU ³ ; Meng ZHANG ³ ; Junchang LIU ⁴ ; Siyan ZHAN ⁵ ; Feng SUN ⁶
Author Information

1. Department of Integration of Chinese and Western Medicine, Department of Geriatric Oncology, Peking University Cancer Hospital and Institution, Beijing, China; Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Centre, Beijing, China; Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing, China
2. Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing, China; Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, China
3. Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Centre, Beijing, China; Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing, China
4. Xinjiang Medical University, Xinjiang, China; Xinjiang Uygur Autonomous Region Academy of Traditional Chinese Medicine, Urumqi, Xinjiang, China
5. Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Centre, Beijing, China; Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing, China; Research Center of Clinical Epidemiology, Peking University Third Hospital, Beijing, China
6. Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Centre, Beijing, China; Key Laboratory of Epidemiology of Major Diseases (Peking University), Ministry of Education, Beijing, China; Xinjiang Medical University, Xinjiang, China; School of Medicine, Shihezi University, Shihezi, China
Publication Type:Journal Article
Keywords: Efficacy; Pregnancy outcomes; Recurrent pregnancy loss; Safety; Traditional Chinese medicine
From: Science of Traditional Chinese Medicine 2026;4(1):87-95
CountryChina
Language:English
Abstract: Background: Recurrent pregnancy loss undermines the physical and mental health of women. Recent randomized controlled trials have reported some effects of traditional Chinese medicine (TCM); however, whether various TCM methods have different effectiveness remains unclear. Objective: To comprehensively evaluate the efficacy and adverse events of TCM for patients with RPL and to explore whether various TCM methods have different effectiveness. Methods: Ten databases were searched up to May 27, 2024. The risk of bias was assessed using the RoB2 tool. The certainty of the evidence was evaluated using the grading of Recommendations, Assessment, Development, and Evaluation tool. Pairwise and network analyses were conducted using Stata 18.0. Results: A total of 47 randomized controlled trials enrolling 6678 women with RPL were included. Pairwise analysis showed that use of TCM had a significantly lower miscarriage rate (RR 0.50 [95% CI 0.45, 0.55]), lower preterm birth rate (RR 0.81 [95% CI 0.67, 0.98), and lower adverse event rate (RR 0.46 [95% CI 0.37, 0.58]). Moreover, use of TCM was associated with a higher alive-fetus rate (RR 1.21 [95% CI 1.15, 1.26]), live-birth rate (RR 1.20 [95% CI 1.15, 1.25]), and full-term rate (RR 1.37 [95% CI 1.23, 1.53]) compared with nonuse of TCM. Network analysis demonstrated that Bushenshugan combined with conventional Western medicine was ranked the best for the reduction of miscarriage rate. Discussion: Use of TCM is more likely to improve pregnancy outcomes and reduce adverse events compared with nonuse of TCM in patients with RPL. Different TCM methods have differences in reducing the miscarriage rate. The Bushenshugan method might be a potential optimal TCM therapy, but more high-quality evidence is needed to further validate and evaluate the efficacy and safety.